Boshi Wang

9PUBLICATIONS
16CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 28, 2026
CDK4/6 Inhibitor-Induced Senescence in Cancer: Mechanisms and Therapeutic Implications.

|Jul 17, 2026
Disruption of CDK4/6-RARα-NF-κB axis attenuates senescence-associated inflammation and improves function during aging and following chemotherapy.

|May 28, 2026
Response to: Limitations of the p16-3MR mouse model for detecting and eliminating senescent cells.

|Feb 10, 2025
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.

Jamil Nehme, Sjors Maassen, Sara Bravaccini

|Apr 23, 2024
The senescence-associated secretory phenotype and its physiological and pathological implications.

Boshi Wang, Jin Han, Jennifer H Elisseeff

|Oct 17, 2022
Sufu- and Spop-mediated regulation of Gli2 is essential for the control of mammalian cochlear hair cell differentiation.

Tianli Qin, Chin Chung Ho, Boshi Wang

Pageof 2

Frequent Collaborators

8 joint publications

Marco Demaria

2 joint publications

Simone M Brandenburg

2 joint publications

Jamil Nehme

1 joint publications

N Basisty